Vimarsana
Biggest News Aggregation in the World

Page 8 - Potential Risk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Potential Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Potential Risk Today - Breaking & Trending Today

Prevalence and Identification of Mange Mites on Cattle - Vimarsana News

Prevalence and Identification of Mange Mites on Cattle

Mange mite is one of skin disease of cattle that can cause huge economic loss through decrease production

UMT re-appoints Mazlan as vice-chancellor for another year | Malaysia - Vimarsana News

UMT re-appoints Mazlan as vice-chancellor for another year | Malaysia

KUALA TERENGGANU, April 18 — Prof Datuk Mazlan Abd Ghaffar has been re-appointed as Universiti Malaysia Terengganu (UMT) vice-chancellor for another year until April 17, 2023. Previously, the university’s deputy vice-chancellor, he was appointed vice-chancellor by Higher Education...

Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19 - Vimarsana News

Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19

/PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates...

Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19 - Vimarsana News

Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19

/PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for bebtelovimab, an antibody that demonstrates...

Endo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Reviewed Journal of Clinical Pharmacology; Data Evaluates Dosing Flexibility in Men With Hypogonadism - Vimarsana News

Endo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Reviewed Journal of Clinical Pharmacology; Data Evaluates Dosing Flexibility in Men With Hypogonadism

/PRNewswire/ -- Pharmacokinetic simulation modeling study predicted more frequent administration with shorter dosing intervals (8 weeks vs. 10 weeks) would...